In older patients, rosiglitazone was associated with increased risk for stroke, heart failure, and mortality compared with pioglitazone

Commentary

Amy T. Wang, Steven A. Smith

Research output: Contribution to journalArticle

3 Citations (Scopus)
Original languageEnglish (US)
JournalAnnals of Internal Medicine
Volume153
Issue number12
StatePublished - Dec 21 2010

Fingerprint

rosiglitazone
pioglitazone
Heart Failure
Stroke
Mortality

ASJC Scopus subject areas

  • Internal Medicine

Cite this

In older patients, rosiglitazone was associated with increased risk for stroke, heart failure, and mortality compared with pioglitazone : Commentary. / Wang, Amy T.; Smith, Steven A.

In: Annals of Internal Medicine, Vol. 153, No. 12, 21.12.2010.

Research output: Contribution to journalArticle

@article{09a488fe9c0c4df9a3a483959959120e,
title = "In older patients, rosiglitazone was associated with increased risk for stroke, heart failure, and mortality compared with pioglitazone: Commentary",
author = "Wang, {Amy T.} and Smith, {Steven A.}",
year = "2010",
month = "12",
day = "21",
language = "English (US)",
volume = "153",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "12",

}

TY - JOUR

T1 - In older patients, rosiglitazone was associated with increased risk for stroke, heart failure, and mortality compared with pioglitazone

T2 - Commentary

AU - Wang, Amy T.

AU - Smith, Steven A.

PY - 2010/12/21

Y1 - 2010/12/21

UR - http://www.scopus.com/inward/record.url?scp=78751627542&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78751627542&partnerID=8YFLogxK

M3 - Article

VL - 153

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 12

ER -